Vermassen, Tijl <br/><br/>
Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  03 2018 
 - 402-408 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfx063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers--blood<br/>Cathepsin D--metabolism<br/>Creatinine--blood<br/>Cystatin C--blood<br/>Female<br/>Glomerular Filtration Rate<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--adverse effects<br/>Neoplasms--drug therapy<br/>Prognosis<br/>Prospective Studies<br/>Protein Kinase Inhibitors--adverse effects<br/>Renal Insufficiency--blood